Abstract
Various side effects associated with dimethyl sulfoxide (DMSO) which is used for cryopreservation of bone marrow or peripheral blood progenitor cells (PBPCs) have been reported. Among the central nervous system side effects the epileptic seizures, stroke, transient and temporary leucoencephalopathy, and global amnesia are well known. Herein we report a 52-year-old man who experienced tonic–clonic seizure within minutes after the initiation of DMSO cryopreserved autologous PBPC infusion. Unfortunately, he also developed cardiac arrest and required intubation for ventilation after the seizure. Pathophysiology of acute neurological and cardiac toxicity is unclear, but may also be idiosyncratic. Clinicians should be aware of the toxicity of cryoprotectant agents during PBSC infusion. Determining the risk factors associated with increased DMSO toxicity and taking preventive actions is utmost important.
This is a preview of subscription content, log in via an institution to check access.
References
Bauwens D, Hantson P, Laterre PF, Michaux L, Latinne D, De Tourtchaninoff M et al (2005) Recurrent seizure and sustained encephalopathy associated with dimethylsulfoxide-preserved stem cell infusion. Leuk Lymphoma 46(11):1671–1674
Chen-Plotkin AS, Vossel KA, Samuels MA, Chen MH (2007) Encephalopathy, stroke, and myocardial infarction with DMSO use in stem cell transplantation. Neurology 68(11):859–861
Hentschke S, Hentschke M, Hummel K, Salwender HJ, Braumann D, Stang A (2006) Bilateral thalamic infarction after reinfusion of DMSO-preserved autologous stem-cells. Leuk Lymphoma 47(11):2418–2420
Hequet O, Dumontet C, El Jaafari-Corbin A, Salles G, Espinouse D, Arnaud P et al (2002) Epileptic seizures after autologous peripheral blood progenitor infusion in a patient treated with high-dose chemotherapy for myeloma. Bone Marrow Transpl 29(6):544
Hoyt R, Szer J, Grigg A (2000) Neurological events associated with the infusion of cryopreserved bone marrow and/or peripheral blood progenitor cells. Bone Marrow Transpl 25(12):1285–1287
Junior AM, Arrais CA, Saboya R, Velasques RD, Junqueira PL, Dulley FL (2008) Neurotoxicity associated with dimethylsulfoxide-preserved hematopoietic progenitor cell infusion. Bone Marrow Transpl 41:95–96
Keung YK, Lau S, Elkayam U, Chen SC, Douer D (1994) Cardiac arrhythmia after infusion of cryopreserved stem cells. Bone Marrow Transpl 14(3):363–367
Mueller LP, Theurich S, Christopeit M, Grothe W, Muetherig A, Weber T et al (2007) Neurotoxicity upon infusion of dimethylsulfoxide-cryopreserved peripheral blood stem cells in patients with and without pre-existing cerebral disease. Eur J Haematol 78(6):527–531
Otrock ZK, Beydoun A, Barada WM, Masroujeh R, Hourani R, Bazarbachi A et al (2008) Transient global amnesia associated with the infusion of DMSO-cryopreserved autologous peripheral blood stem cells. Haematologica 93(3):e36–e37
Ruiz-Delgado GJ, Mancías-Guerra C, Tamez-Gómez EL, Rodríguez-Romo LN, López-Otero A, Hernández-Arizpe A et al (2009) Dimethyl sulfoxide-induced toxicity in cord blood stem cell transplantation: report of three cases and review of the literature. Acta Haematol 122:1–5
Windrum P, Morris TC (2003) Severe neurotoxicity because of dimethyl sulphoxide following peripheral blood stem cell transplantation. Bone Marrow Transpl 31(4):315
Author information
Authors and Affiliations
Corresponding author
Rights and permissions
About this article
Cite this article
Maral, S., Albayrak, M., Pala, C. et al. Dimethyl Sulfoxide-Induced Tonic-Clonic Seizure and Cardiac Arrest During Infusion of Autologous Peripheral Blood Stem Cells. Cell Tissue Bank 19, 831–832 (2018). https://doi.org/10.1007/s10561-018-9718-x
Received:
Accepted:
Published:
Issue Date:
DOI: https://doi.org/10.1007/s10561-018-9718-x